Fulgent Genetics, Inc. (FLGT) › Cost of RevenueFulgent Genetics, Inc. (FLGT) — Cost of RevenueAnnual figures by period end, from SEC filings.2014-12-31: $936.0K2015-12-31: $5.07M2016-12-31: $6.72M2017-12-31: $8.55M2018-12-31: $10.70M2019-12-31: $14.11M2020-12-31: $89.81M2021-12-31: $215.53M2022-12-31: $252.07M2023-12-31: $184.76M2024-12-31: $176.25M2025-12-31: $191.80M$191.80M2014-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$191.80M+8.8%2026-02-27From 2025-01-012024-12-31$176.25M-4.6%2026-02-27From 2024-01-012023-12-31$184.76M-26.7%2026-02-27From 2023-01-012022-12-31$252.07M+17.0%2025-02-28From 2022-01-012021-12-31$215.53M+140.0%2024-02-28From 2021-01-012020-12-31$89.81M+536.6%2023-02-28From 2020-01-012019-12-31$14.11M+31.9%2022-02-28From 2019-01-012018-12-31$10.70M+25.1%2020-03-13From 2018-01-012017-12-31$8.55M+27.2%2019-03-22From 2017-01-012016-12-31$6.72M+32.6%2018-03-20From 2016-01-012015-12-31$5.07M+441.6%2017-03-17From 2015-01-012014-12-31$936.0K—2017-03-17From 2014-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)